Published in

Elsevier, Annals of Oncology, (32), p. S1406, 2021

DOI: 10.1016/j.annonc.2021.10.097

Links

Tools

Export citation

Search in Google Scholar

79P Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO